Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Dosage Regimen: Individualization

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Pharmacogenetics of Drug Metabolism: Overview

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Training types associated with knowledge and experience in public health workers.

Archives of public health = Archives belges de sante publique·2022

Same author

The impact of COVID-19 on inpatient wards at psychiatric hospitals in Japan.

Asian journal of psychiatry·2021

Same author

Number of long-term inpatients in Japanese psychiatric care beds: trend analysis from the patient survey and the 630 survey.

BMC psychiatry·2020

Same author

National database study on the use of long-acting antipsychotic injections and hospital readmission proportions in patients with schizophrenia in Japan.

Psychiatry and clinical neurosciences·2019

Same author

Present and future of severe mental illness (SMI) policies: Reflections from an Asia-Pacific Expert Forum series.

Psychiatry and clinical neurosciences·2019

Same author

Switching to antipsychotic monotherapy vs. staying on antipsychotic polypharmacy in schizophrenia: A systematic review and meta-analysis.

Schizophrenia research·2019

Same journal

[The Current Issues of Crime Victim Support from a Clinical Point of View].

Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica·2019

Same journal

[The Role of Psychiatrists as Personal Support Specialists].

Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica·2019

Same journal

[Historical Re-evaluation of the System of Sending Psychiatrists to Okinawa and the Activities of the Japanese Society of Psychiatry and Neurology].

Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica·2019

Same journal

[Background of Okinawa's Acceptance of Dispatched Physicians and Its Current Status].

Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica·2019

Same journal

[Medical Dispatch to Okinawa and following Period].

Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica·2019

Same journal

[The Situation of Psychiatric Medicine and the System of Dispatching Medical Doctors Half a Century Ago in Okinawa].

Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica·2019

See all related articles

Search research articles

Related Experiment Video

Updated: May 20, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

[How everyone recognize about polypharmacy?].

Yoshio Yamanouchi¹

¹Department of Psychiatry, Fujita Health University School of Medicine.

Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica

|August 1, 2012

Summary

This summary is machine-generated.

Japanese antipsychotic polypharmacy may exceed other countries, raising concerns about psychiatric medication quality. A new clinical study aims to assess the safety and effectiveness of this medication practice in schizophrenia patients.

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap² Method

Published on: May 21, 2018

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Related Experiment Videos

Last Updated: May 20, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap² Method

Published on: May 21, 2018

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Area of Science:

Psychiatry
Pharmacology
Public Health

Background:

Investigations suggest higher antipsychotic dosage and number in Japan compared to other countries.
Concerns regarding psychiatric medication quality, specifically antipsychotic polypharmacy and extensive medication, were raised by a 2009 Japanese Ministry of Health, Labour and Welfare conference.
The conference report highlighted the need to understand the actual conditions of polypharmacy and extensive antipsychotic medication in schizophrenia patients to improve treatment quality.

Purpose of the Study:

To investigate the actual condition of antipsychotic polypharmacy and extensive medication in Japanese schizophrenia patients.
To evaluate the safety and effectiveness of antipsychotic polypharmacy and extensive medication.
To provide evidence for potential improvements in psychiatric medication quality.

Main Methods:

A clinical study is currently underway.
The study focuses on schizophrenia patients in Japan.
Data collection will assess polypharmacy and extensive medication practices.

Main Results:

No evidence currently exists to determine if polypharmacy is beneficial or detrimental.
The actual condition of antipsychotic medication practices in Japan remains largely unknown.
This study aims to fill this knowledge gap.

Conclusions:

Understanding the current landscape of antipsychotic medication is crucial for quality improvement.
Further research is needed to establish the safety and efficacy of current practices.
This study will contribute evidence-based insights into antipsychotic polypharmacy in schizophrenia.